% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • naked_finger naked_finger May 11, 2012 10:34 AM Flag

    ECYT is the next ARNA, see below

    EC145 Overian Phase III
    EC145 Small Lung Phase II2b
    EC145 3rd New Application Treatment
    EC145 4th
    EC145 5th
    EC145 6th

    All this year / begin of 2013 and Merck will pay
    880 mln Milestone
    239 mln Cash / $6,90

    50% of US Profits
    Double Digit Profit non US -EC 145

    Very Good FPS results in FR++

    EC0531 folate-tubulysin, solide tumors

    PSMA-tubulysin, prostate cancer

    PSMA-Tc99m prostate cancer imaging

    EC0746 and EC0565, folate-drug conjugates, anti-inflammation

1.62+0.03(+1.89%)May 26 4:00 PMEDT